Beam Therapeutics Inc Cash Flow Quality Index

Latest as of December 2025: -0.34x

Beam Therapeutics Inc cash flow quality index. Beam Therapeutics Inc (BEAM) has a Cash Flow Quality Index of -0.34x as of December 2025. Operating cash flow of $-83.29 Million is below net income of $244.30 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow to debt ratio of Beam Therapeutics Inc to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-0.34x
Operating CF / Net Income

Operating Cash Flow

$-83.29 Million
USD

Net Income

$244.30 Million
USD

Data as of

Dec 2025
Most recent filing

Beam Therapeutics Inc Cash Flow Quality Index by Year (None–None)

Beam Therapeutics Inc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Beam Therapeutics Inc. For the full cash flow conversion analysis, see how efficiently does Beam Therapeutics Inc generate cash.

Year Quality Index Operating CF (USD) Net Income YoY Change
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.